RAPATED: Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric Population

Sponsor
Ramsay Générale de Santé (Other)
Overall Status
Unknown status
CT.gov ID
NCT04846855
Collaborator
Hôpital Privé Claude Galien-Service Dr Maupain (Other)
100
1
1
12.4
8.1

Study Details

Study Description

Brief Summary

Peripheral loco-regional anesthesia (LRA) for anesthetic purposes is a technique widely used in adults for upper limb surgery. In pediatrics, LRA is not classically considered on its own. It is usually performed for analgesic purposes during sedation or general anesthesia. It is entirely possible to carry out awakened peripheral blocks in communicating children, of school age, thus avoiding the issues of GA in pediatrics, in particular in an emergency context. The use of Emla anesthetic skin patches for punctures (perfusion and LRA) as well as the viewing of cartoons on touch tablets during treatment can improve the perception of painless care such as LRA and treatment.

In pediatrics, only ropivacaine at a concentration of 0.2% has Marketing Authorization in pediatrics in children under 12 for the production of peripheral blocks. On the basis of the experience of the Claude Galien Private Hospital in this area, it seems interesting to assess the feasibility of upper limb surgery under anesthetic LRA alone with a dose of ropivacaine at the concentration 0.35% in communicating children, of school age.

Condition or Disease Intervention/Treatment Phase
  • Drug: local anaesthetic injection
Phase 4

Detailed Description

Peripheral loco-regional anesthesia (LRA) for anesthetic purposes is a technique widely used in adults for upper limb surgery. It allows peripheral surgeries to be performed without putting the patient to sleep and thus avoiding certain disadvantages of general anesthesia (GA).

In pediatrics, LRA is not classically considered on its own. It is usually performed for analgesic purposes during sedation or GA.

Subject to respecting a strict protocol and taking advantage of considerable developments in the field of LRA, it is entirely possible to carry out awakened peripheral blocks in communicating children, of school age, thus avoiding the pitfalls of GA in pediatrics, in particular in an emergency context (inhalation on a full stomach, respiratory risk in children with colds, inhalational anesthesia with an anxiety mask, postoperative vomiting nausea, disorientation and delusions upon waking ...) Indeed, the exclusive use of ultrasound, the use of adapted needles, the improvement of knowledge in sono-anatomy, the reduction in doses and concentrations of local anesthetics are all developments in the field of LRA allowing to improve the conditions of safety, comfort for the patient and success of the technique.

Beyond technical considerations, there are ways to improve the child's experience with care. The use of Emla anesthetic skin patches for punctures (perfusion and ALR) as well as the viewing of cartoons on touch tablets during treatment can improve the perception of painless care such as ALR and treatment. charge in the operating room.

In pediatrics, only ropivacaine at a concentration of 0.2% has Marketing Authorization in pediatrics in children under 12 for the production of peripheral blocks. Higher concentrations of ropivacaine, used in several pediatric studies, have nevertheless shown their good tolerance and their efficacy Under reserve not to exceed 3mg / kg and to use concentrations up to 0.5% On the basis of these arguments, and with the experience of the Claude Galien Private Hospital in this area, it seems interesting to assess the feasibility of upper limb surgery under anesthetic ALR alone with a dose of ropivacaine at the concentration 0.35% in communicating children, of school age.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
monocentric, interventional, longitudinal, prospective, non-comparative.monocentric, interventional, longitudinal, prospective, non-comparative.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric Population- RAPATED
Actual Study Start Date :
Sep 18, 2020
Anticipated Primary Completion Date :
Sep 30, 2021
Anticipated Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ropivacaine 35%

Local Anesthesia with Ropivacaine

Drug: local anaesthetic injection
Realization by the anesthesiologist of the local anesthesia by single dose of ropivacaine 0.35% in perinervous under ultrasound with distraction by a tablette.

Outcome Measures

Primary Outcome Measures

  1. LRA succes [2 hours]

    percentage of children in whom ALR and surgery were performed without additional sedation or general anesthesia.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Child aged 6 to 12.

  • Able to understand and express themselves.

  • Intended for orthopedic surgery of the upper limb involving the hand, wrist, forearm or elbow.

  • ASA class 1-2.

  • Patient who has given free and informed consent.

  • Parent present having given their free and informed consent.

  • Affiliated patient or beneficiary of a social security scheme

Exclusion Criteria:
  • Refusal of the child and / or parent to participate in the study.

  • Immediate vital emergency.

  • Duration of planned surgery> 1h30.

  • History of allergy to LA.

  • Contraindication to carrying out ALR (local infection, pathology contraindicating ALR, preoperative neurological deficit).

  • Refusal by the surgeon.

  • Child already sedated or premedicated in the emergency room.

  • Digital tablet not available.

  • Patient participating in another clinical study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Privé d'Antony Antony IDF France 92160

Sponsors and Collaborators

  • Ramsay Générale de Santé
  • Hôpital Privé Claude Galien-Service Dr Maupain

Investigators

  • Principal Investigator: Jean Sende, PHD, Ramsay santé

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ramsay Générale de Santé
ClinicalTrials.gov Identifier:
NCT04846855
Other Study ID Numbers:
  • 2018-A03402-53
First Posted:
Apr 15, 2021
Last Update Posted:
Apr 15, 2021
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ramsay Générale de Santé
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 15, 2021